Insulin and blood pressure: Connected on a circumference?

Hypertension

Volumn 45, Issue 3, 2005, Pages 347-348

  Ferrannini, Ele ^a,b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID;

BLOOD PRESSURE MEASUREMENT; BODY FAT; EDITORIAL; HOMEOSTASIS; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN METABOLISM; INSULIN RESISTANCE; LIPID ANALYSIS; LONGITUDINAL STUDY; OBESITY; PREVALENCE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ABDOMEN; ADIPOSE TISSUE; BLOOD PRESSURE; HUMANS; INSULIN;

EID: 14644395575     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000155464.44905.6c     Document Type: Editorial

References (13)

1. Ferrannini E. The phenomenon of insulin resistance: its possible relevance to hypertensive disease. In: Laragh JH, Brenner BM. eds. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd ed. New York, NY: Raven Press; 1995:2281-2300.
2. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
4. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol. 1998;81(4A):18B-25B.
5. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H. Insulin resistance, hyperinsulinemia, and blood pressure. Role of age and obesity. Hypertension. 1997;30:1144-1149.
6. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Metabolic precursors of hypertension. The San Antonio Heart Study. Arch Intern Med. 1996;156: 1994-2001.
7. Poirier P, Lemieux I, Mauriège P, Dewailly E, Blanchet C, Bergeron J, Després JP. Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension. 2005;45:363-367.
8. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation. 2003;108:1718-1723.
9. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Buzzigoli E, Ghione S, Turchi S, Lombardi M, Ferrannini E. Visceral fat in hypertension: influence on insulin resistance and β-cell function. Hypertension. 2004;44:127-133.
10. Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, Zaccaro D, Bergman RN, Savage PJ, Haffner SM. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension. 2004;43:1324-1331.
11. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med. 2004;140: 992-1000.
12. Sharma AM. Mediastinal fat, insulin resistance, and hypertension. Hypertension. 2004;44:117-118.
13. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89: 2563-2568.